vs

Side-by-side financial comparison of REPLIGEN CORP (RGEN) and Tenable Holdings, Inc. (TENB). Click either name above to swap in a different company.

Tenable Holdings, Inc. is the larger business by last-quarter revenue ($262.1M vs $194.3M, roughly 1.3× REPLIGEN CORP). REPLIGEN CORP runs the higher net margin — 4.3% vs 0.5%, a 3.8% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (14.8% vs 9.6%). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (12.3% CAGR vs 8.8%).

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

Tenable Holdings, Inc. is a cybersecurity company based in Columbia, Maryland. Its vulnerability scanner software Nessus, developed in 1998, is one of the most widely deployed vulnerability assessment solutions in the cybersecurity industry. As of December 31, 2023, the company had approximately 44,000 customers, including 65% of the Fortune 500.

RGEN vs TENB — Head-to-Head

Bigger by revenue
TENB
TENB
1.3× larger
TENB
$262.1M
$194.3M
RGEN
Growing faster (revenue YoY)
RGEN
RGEN
+5.2% gap
RGEN
14.8%
9.6%
TENB
Higher net margin
RGEN
RGEN
3.8% more per $
RGEN
4.3%
0.5%
TENB
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
12.3%
8.8%
TENB

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
RGEN
RGEN
TENB
TENB
Revenue
$194.3M
$262.1M
Net Profit
$8.3M
$1.4M
Gross Margin
55.7%
78.4%
Operating Margin
8.2%
25.0%
Net Margin
4.3%
0.5%
Revenue YoY
14.8%
9.6%
Net Profit YoY
42.9%
EPS (diluted)
$0.15
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RGEN
RGEN
TENB
TENB
Q1 26
$194.3M
$262.1M
Q4 25
$197.9M
$260.5M
Q3 25
$188.8M
$252.4M
Q2 25
$182.4M
$247.3M
Q1 25
$169.2M
$239.1M
Q4 24
$174.1M
$235.7M
Q3 24
$154.9M
$227.1M
Q2 24
$154.1M
$221.2M
Net Profit
RGEN
RGEN
TENB
TENB
Q1 26
$8.3M
$1.4M
Q4 25
$13.3M
$-737.0K
Q3 25
$14.9M
$2.3M
Q2 25
$14.9M
$-14.7M
Q1 25
$5.8M
$-22.9M
Q4 24
$-30.3M
$1.9M
Q3 24
$-654.0K
$-9.2M
Q2 24
$3.3M
$-14.6M
Gross Margin
RGEN
RGEN
TENB
TENB
Q1 26
55.7%
78.4%
Q4 25
52.5%
78.8%
Q3 25
53.2%
77.5%
Q2 25
50.0%
78.0%
Q1 25
53.6%
78.1%
Q4 24
26.1%
78.2%
Q3 24
50.0%
77.8%
Q2 24
49.8%
77.9%
Operating Margin
RGEN
RGEN
TENB
TENB
Q1 26
8.2%
25.0%
Q4 25
9.0%
3.4%
Q3 25
8.9%
2.8%
Q2 25
7.6%
-3.0%
Q1 25
3.9%
-7.4%
Q4 24
-17.7%
5.5%
Q3 24
-5.1%
-0.9%
Q2 24
1.0%
-4.0%
Net Margin
RGEN
RGEN
TENB
TENB
Q1 26
4.3%
0.5%
Q4 25
6.7%
-0.3%
Q3 25
7.9%
0.9%
Q2 25
8.2%
-5.9%
Q1 25
3.4%
-9.6%
Q4 24
-17.4%
0.8%
Q3 24
-0.4%
-4.1%
Q2 24
2.2%
-6.6%
EPS (diluted)
RGEN
RGEN
TENB
TENB
Q1 26
$0.15
$0.01
Q4 25
$0.24
$-0.01
Q3 25
$0.26
$0.02
Q2 25
$0.26
$-0.12
Q1 25
$0.10
$-0.19
Q4 24
$-0.55
$0.01
Q3 24
$-0.01
$-0.08
Q2 24
$0.06
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RGEN
RGEN
TENB
TENB
Cash + ST InvestmentsLiquidity on hand
$582.6M
$360.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$248.2M
Total Assets
$2.9B
$1.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RGEN
RGEN
TENB
TENB
Q1 26
$582.6M
$360.3M
Q4 25
$767.6M
$402.2M
Q3 25
$748.7M
$383.6M
Q2 25
$708.9M
$386.5M
Q1 25
$697.2M
$460.3M
Q4 24
$757.4M
$577.2M
Q3 24
$784.0M
$548.4M
Q2 24
$809.1M
$487.0M
Total Debt
RGEN
RGEN
TENB
TENB
Q1 26
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Stockholders' Equity
RGEN
RGEN
TENB
TENB
Q1 26
$248.2M
Q4 25
$2.1B
$326.4M
Q3 25
$2.1B
$344.4M
Q2 25
$2.1B
$350.7M
Q1 25
$2.0B
$383.2M
Q4 24
$2.0B
$400.0M
Q3 24
$2.0B
$404.6M
Q2 24
$2.0B
$363.6M
Total Assets
RGEN
RGEN
TENB
TENB
Q1 26
$2.9B
$1.6B
Q4 25
$2.9B
$1.7B
Q3 25
$2.9B
$1.7B
Q2 25
$2.9B
$1.7B
Q1 25
$2.9B
$1.7B
Q4 24
$2.8B
$1.7B
Q3 24
$2.8B
$1.6B
Q2 24
$2.9B
$1.6B
Debt / Equity
RGEN
RGEN
TENB
TENB
Q1 26
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RGEN
RGEN
TENB
TENB
Operating Cash FlowLast quarter
$88.0M
Free Cash FlowOCF − Capex
$82.6M
FCF MarginFCF / Revenue
31.5%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
62.21×
TTM Free Cash FlowTrailing 4 quarters
$256.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RGEN
RGEN
TENB
TENB
Q1 26
$88.0M
Q4 25
$25.7M
$83.0M
Q3 25
$48.1M
$53.9M
Q2 25
$28.6M
$42.5M
Q1 25
$15.0M
$87.4M
Q4 24
$39.2M
$81.1M
Q3 24
$49.3M
$54.6M
Q2 24
$42.2M
$31.4M
Free Cash Flow
RGEN
RGEN
TENB
TENB
Q1 26
$82.6M
Q4 25
$17.6M
$82.7M
Q3 25
$43.4M
$53.0M
Q2 25
$21.5M
$38.1M
Q1 25
$11.4M
$80.9M
Q4 24
$33.6M
$78.8M
Q3 24
$42.3M
$53.9M
Q2 24
$37.4M
$30.9M
FCF Margin
RGEN
RGEN
TENB
TENB
Q1 26
31.5%
Q4 25
8.9%
31.7%
Q3 25
23.0%
21.0%
Q2 25
11.8%
15.4%
Q1 25
6.8%
33.8%
Q4 24
19.3%
33.4%
Q3 24
27.3%
23.7%
Q2 24
24.3%
14.0%
Capex Intensity
RGEN
RGEN
TENB
TENB
Q1 26
Q4 25
4.1%
0.1%
Q3 25
2.5%
0.3%
Q2 25
3.9%
1.8%
Q1 25
2.1%
2.7%
Q4 24
3.2%
1.0%
Q3 24
4.5%
0.3%
Q2 24
3.1%
0.2%
Cash Conversion
RGEN
RGEN
TENB
TENB
Q1 26
62.21×
Q4 25
1.93×
Q3 25
3.23×
23.83×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
43.43×
Q3 24
Q2 24
12.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RGEN
RGEN

Product$194.2M100%
Royalty and other revenue$44.0K0%

TENB
TENB

Subscription revenue$243.2M93%
Perpetual license and maintenance revenue$10.2M4%
Other$8.7M3%

Related Comparisons